nasal
First Nasal Spray for Treatment of Anaphylaxis approved by FDA
August 12, 2024Research and Development Emergency Medicine, FDA, anaphylaxis, epinephrine, nasal
ARS Pharmaceuticals has been granted approval by the US Food and Drug Administration (FDA) for their epinephrine nasal spray, neffy, …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
